Global Cervical Cancer Test Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1635

Cervical cancer is one of the deadliest cancers among woman all over the world. However in the past few decades, mortality from cervical cancer has significantly decreased in developed countries due to widely use of Pap smear test. HPV DNA and VIA test are other popular tests used across world. VIA test is most adoptable test in developing countries as it is cheaper in comparison to Pap smear test and HPV DNA test.
Cervical cancer test market is dominated by United States in 2018. Germany and United Kingdom are other top two leaders in this market place. In Asian region, China and India are top two countries having largest cervical cancer test population. Few countries have also shown a decline in cervical cancer test market. However VIA test market accounts for largest share in cervical cancer test market in the case of developing countries like India and China.
A high prevalence of HPV-infected patients across the globe, rising incidences of teenage sexual cases, a rising number of organized cervical cancer programs initiated by governments and NGOs and introduction of low cost VIA test are some of the major growth drivers for the cervical cancer test market. However, lack of insufficient healthcare infrastructure and lack of cervical cancer screening awareness are the major hinder for cervical testing market.
In 2018, the global Cervical Cancer Test market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Cervical Cancer Test status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cervical Cancer Test development in United States, Europe and China.

The key players covered in this study
Hologic
Qiagen N.V.
Becton, Dickinson and Company
Hoffman-La Roche
Abbott Molecular
Arbor Vita Corporation
OncoHealth Corporation
Dell Guided Therapeutics, Inc.
CooperSurgical, Inc.

Market segment by Type, the product can be split into
Pap Smear Test
HPV DNA Test
VIA Test

Market segment by Application, split into
Hospitals
Laboratories
Physicians’ Offices & Clinics

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Cervical Cancer Test status, future forecast, growth opportunity, key market and key players.
To present the Cervical Cancer Test development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Cervical Cancer Test are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cervical Cancer Test Market Size Growth Rate by Type (2014-2025)
1.4.2 Pap Smear Test
1.4.3 HPV DNA Test
1.4.4 VIA Test
1.5 Market by Application
1.5.1 Global Cervical Cancer Test Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Laboratories
1.5.4 Physicians’ Offices & Clinics
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Cervical Cancer Test Market Size
2.2 Cervical Cancer Test Growth Trends by Regions
2.2.1 Cervical Cancer Test Market Size by Regions (2014-2025)
2.2.2 Cervical Cancer Test Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Cervical Cancer Test Market Size by Manufacturers
3.1.1 Global Cervical Cancer Test Revenue by Manufacturers (2014-2019)
3.1.2 Global Cervical Cancer Test Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Cervical Cancer Test Market Concentration Ratio (CR5 and HHI)
3.2 Cervical Cancer Test Key Players Head office and Area Served
3.3 Key Players Cervical Cancer Test Product/Solution/Service
3.4 Date of Enter into Cervical Cancer Test Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Cervical Cancer Test Market Size by Type (2014-2019)
4.2 Global Cervical Cancer Test Market Size by Application (2014-2019)

5 United States
5.1 United States Cervical Cancer Test Market Size (2014-2019)
5.2 Cervical Cancer Test Key Players in United States
5.3 United States Cervical Cancer Test Market Size by Type
5.4 United States Cervical Cancer Test Market Size by Application

6 Europe
6.1 Europe Cervical Cancer Test Market Size (2014-2019)
6.2 Cervical Cancer Test Key Players in Europe
6.3 Europe Cervical Cancer Test Market Size by Type
6.4 Europe Cervical Cancer Test Market Size by Application

7 China
7.1 China Cervical Cancer Test Market Size (2014-2019)
7.2 Cervical Cancer Test Key Players in China
7.3 China Cervical Cancer Test Market Size by Type
7.4 China Cervical Cancer Test Market Size by Application

8 Japan
8.1 Japan Cervical Cancer Test Market Size (2014-2019)
8.2 Cervical Cancer Test Key Players in Japan
8.3 Japan Cervical Cancer Test Market Size by Type
8.4 Japan Cervical Cancer Test Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Cervical Cancer Test Market Size (2014-2019)
9.2 Cervical Cancer Test Key Players in Southeast Asia
9.3 Southeast Asia Cervical Cancer Test Market Size by Type
9.4 Southeast Asia Cervical Cancer Test Market Size by Application

10 India
10.1 India Cervical Cancer Test Market Size (2014-2019)
10.2 Cervical Cancer Test Key Players in India
10.3 India Cervical Cancer Test Market Size by Type
10.4 India Cervical Cancer Test Market Size by Application

11 Central & South America
11.1 Central & South America Cervical Cancer Test Market Size (2014-2019)
11.2 Cervical Cancer Test Key Players in Central & South America
11.3 Central & South America Cervical Cancer Test Market Size by Type
11.4 Central & South America Cervical Cancer Test Market Size by Application

12 International Players Profiles
12.1 Hologic
12.1.1 Hologic Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cervical Cancer Test Introduction
12.1.4 Hologic Revenue in Cervical Cancer Test Business (2014-2019)
12.1.5 Hologic Recent Development
12.2 Qiagen N.V.
12.2.1 Qiagen N.V. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cervical Cancer Test Introduction
12.2.4 Qiagen N.V. Revenue in Cervical Cancer Test Business (2014-2019)
12.2.5 Qiagen N.V. Recent Development
12.3 Becton, Dickinson and Company
12.3.1 Becton, Dickinson and Company Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cervical Cancer Test Introduction
12.3.4 Becton, Dickinson and Company Revenue in Cervical Cancer Test Business (2014-2019)
12.3.5 Becton, Dickinson and Company Recent Development
12.4 Hoffman-La Roche
12.4.1 Hoffman-La Roche Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cervical Cancer Test Introduction
12.4.4 Hoffman-La Roche Revenue in Cervical Cancer Test Business (2014-2019)
12.4.5 Hoffman-La Roche Recent Development
12.5 Abbott Molecular
12.5.1 Abbott Molecular Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cervical Cancer Test Introduction
12.5.4 Abbott Molecular Revenue in Cervical Cancer Test Business (2014-2019)
12.5.5 Abbott Molecular Recent Development
12.6 Arbor Vita Corporation
12.6.1 Arbor Vita Corporation Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cervical Cancer Test Introduction
12.6.4 Arbor Vita Corporation Revenue in Cervical Cancer Test Business (2014-2019)
12.6.5 Arbor Vita Corporation Recent Development
12.7 OncoHealth Corporation
12.7.1 OncoHealth Corporation Company Details
12.7.2 Company Description and Business Overview
12.7.3 Cervical Cancer Test Introduction
12.7.4 OncoHealth Corporation Revenue in Cervical Cancer Test Business (2014-2019)
12.7.5 OncoHealth Corporation Recent Development
12.8 Dell Guided Therapeutics, Inc.
12.8.1 Dell Guided Therapeutics, Inc. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Cervical Cancer Test Introduction
12.8.4 Dell Guided Therapeutics, Inc. Revenue in Cervical Cancer Test Business (2014-2019)
12.8.5 Dell Guided Therapeutics, Inc. Recent Development
12.9 CooperSurgical, Inc.
12.9.1 CooperSurgical, Inc. Company Details
12.9.2 Company Description and Business Overview
12.9.3 Cervical Cancer Test Introduction
12.9.4 CooperSurgical, Inc. Revenue in Cervical Cancer Test Business (2014-2019)
12.9.5 CooperSurgical, Inc. Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details